Clinical and genetic predictors of response to narrowband ultraviolet B for the treatment of chronic plaque psoriasis

British Journal of Dermatology

Volumn 163, Issue 5, 2010, Pages 1056-1063

  Ryan, C ^a   Renfro, L ^b   Collins, P ^a   Kirby, B ^a   Rogers, S ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Narrowband ultraviolet B; Phototherapy; Psoriasis; Single nucleotide polymorphism; Vitamin D receptor

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; ALLELE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; EXPOSURE; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARAMETER; PHOTOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS VULGARIS; RELAPSE; REMISSION; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION;

ADULT; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; PSORIASIS; RECEPTORS, CALCITRIOL; SEVERITY OF ILLNESS INDEX; ULTRAVIOLET THERAPY;

EID: 78249241521     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09985.x     Document Type: Article

References (39)

1. Parish JA, Jaenicke KF,. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981; 76: 359 -62.
2. Van Weelden H, De La Faille HB, Young E, Van Der Leun JC,. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1988; 119: 11 -19.
3. Dawe RS,. A quantitative review of studies comparing the efficacy of narrow-band and broad-band ultraviolet B for psoriasis. Br J Dermatol 2003; 149: 669 -72.
4. Dawe RS, Cameron H, Yule S, et al. A randomized controlled trial of narrowband ultraviolet B vs. bath-psoralen plus ultraviolet A photochemotherapy. Br J Dermatol 2003; 148: 1194 -204.
5. Markham T, Rogers S, Collins P,. Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for treatment of chronic plaque psoriasis. Arch Dermatol 2003; 139: 325 -8.
6. Ibbotson SH, Bilsland D, Cox NH, et al. An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report. Br J Dermatol 2004; 151: 283 -97.
7. Green C, Lakshmipathi T, Johnson BE, Ferguson J,. A comparison of the efficacy and relapse rates of narrowband UVB (TL-01) monotherapy vs. etretinate (re-TL-01) vs. etretinate-PUVA (re-PUVA) in the treatment of psoriasis patients. Br J Dermatol 1992; 127: 5 -9.
8. Kirke S, Lowder S, Lloyd JJ, et al. A randomized comparison of selective broadband UVB and narrowband UVB in the treatment of psoriasis. J Invest Dermatol 2007; 127: 1641 -6.
9. Kleinpenning MM, Smits T, Boezeman J, et al. Narrowband ultraviolet B therapy in psoriasis: randomized double-blind comparison of high-dose and low-dose irradiation regimens. Br J Dermatol 2009; 161: 1351 -6.
10. Cameron H, Dawe RS, Yule S, et al. A randomized, observer-blinded trial of twice versus three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis. Br J Dermatol 2002; 147: 973 -8.
11. Morris M,. A discussion on the treatment of psoriasis. Br Med J 1902; 2: 1328 -31.
12. Ingram JT,. The significance and management of psoriasis. Br Med J 1954; 4892: 823 -8.
13. Ryan C, Moran B, McKenna MJ, et al. The effect of narrowband ultraviolet B treatment for psoriasis on vitamin D status during wintertime in Ireland. Arch Dermatol 2010; 146: 836 -42.
14. Osmancevic A, Landin-Wilhelmsen K, Larko O, et al. Vitamin D production in psoriasis patients increases less with narrowband than with broadband ultraviolet B phototherapy. Photodermatol Photoimmunol Photomed 2009; 25: 119 -23.
15. Griffin MD, Lutz W, Phan VA, et al. Dendritic cell modulation by 1 alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 2001; 98: 6800 -5.
16. Adorini L, Penna G, Giarratana N, Uskokovic M,. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J Cell Biochem 2003; 88: 227 -33.
17. Griffin MD, Dong X, Kumar R,. Vitamin D receptor-mediated suppression of RelB in antigen presenting cells: a paradigm for ligand-augmented negative transcriptional regulation. Arch Biochem Biophys 2007; 460: 218 -26.
18. Reichrath J, Rappl G,. Ultraviolet light (UV)-induced immunosuppression: is vitamin D the missing link? J Cell Biochem 2003; 89: 6 -8.
19. Milde P, Hauser U, Simon T, et al. Expression of 1,25-dihydroxyvitamin D3 receptors in normal and psoriatic skin. J Invest Dermatol 1991; 97: 230 -9.
20. Fredriksson T, Pettersson U,. Severe psoriasis -oral therapy with a new retinoid. Dermatologica 1978; 157: 238 -44.
21. Finlay AY, Khan GK,. Dermatology Life Quality Index -a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210 -16.
22. Klein JP, Moeschberger ML,. Survival Analysis: Techniques for Censored and Truncated Data, 2nd edn. New York: Springer-Verlag, 2003.
23. Lin D, Wei LJ, Ying Z,. Checking the Cox model with cumulative sums of Martingale-based residuals. Biometrika 1993; 80: 557 -72.
24. Tanew A, Radakovic-Fijan S, Schemper M, Hönigsmann H,. Narrowband UV-B phototherapy vs phochemotherapy in the treatment of chronic plaque psoriasis. Arch Dermatol 1999; 135: 519 -24.
25. Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137: 280 -4.
26. Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41: 401 -7.
27. Fortune DG, Richards HL, Kirby B,. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 2003; 139: 752 -6.
28. Gisondi P, Del Giglio M, Di Francesco V, et al. Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. Am J Clin Nutr 2008; 88: 1242 -7.
29. Halsall JA, Osbourne JE, Pringle JH, Hutchinson PE,. Vitamin D receptor gene polymorphisms, particularly the novel A-1012G promoter polymorphism, are associated with vitamin D3 responsiveness and non-familial susceptibility in psoriasis. Pharmacogenet Genomics 2005; 15: 349 -55.
30. Chen ML, Perez A, Sanan DK, et al. Induction of vitamin D receptor mRNA expression in psoriatic plaques correlates with clinical response to 1,25-dihydroxyvitamin D3. J Invest Dermatol 1996; 106: 637 -41.
31. Dayangac-Erden D, Karaduman A, Erdem-Yurter H,. Polymorphisms of vitamin D receptor gene in Turkish familial psoriasis patients. Arch Dermatol Res 2007; 299: 487 -91.
32. Saeki H, Asano N, Tsunemi Y, et al. Polymorphisms of vitamin D receptor gene in Japanese patients with psoriasis vulgaris. J Dermatol Sci 2002; 30: 167 -71.
33. Kontula K, Valimaki S, Kaingulainen K, et al. Vitamin D receptor polymorphism and treatment of psoriasis with calcipotriol. Br J Dermatol 1997; 136: 977 -8.
34. Lee DY, Park BS, Choi KH, et al. Vitamin D receptor genotypes are not associated with clinical response to calcipotriol in Korean psoriasis patients. Arch Dermatol Res 2002; 294: 1 -5.
35. Mee JB, Cork MJ,. Vitamin D receptor polymorphism and calcipotriol response in patients with psoriasis. J Invest Dermatol 1998; 110: 301 -2.
36. Stern RS, Lunder EJ,. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA) -a meta-analysis. Arch Dermatol 1998; 134: 1582 -5.
37. Stern RS, Thibodeau LA, Parrish JA, Fitzpatrick TB,. Skin cancer risk after PUVA treatment for psoriasis. N Engl J Med 1979; 30: 555.
38. Young AR,. Carcinogenicity of UVB phototherapy assessed. Lancet 1995; 345: 1431 -2.
39. Hearn RM, Kerr AC, Rahim KF, et al. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol 2008; 159: 931 -5.